N6-methyladenosine-modified CircRNA-SORE sustains sorafenib resistance in hepatocellular carcinoma by regulating β-catenin signaling

Overview of attention for article published in Molecular Cancer, November 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (55th percentile)
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 178 Dimensions

Readers on

mendeley: 45 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 1,842 followers.

RT @jonmoulton: N6-methyladenosine-modified CircRNA-SORE sustains sorafenib resistance in hepatocellular carcinoma by regulating β-catenin…

01 May 2021

Reply Repost Favourite

RT @jonmoulton: N6-methyladenosine-modified CircRNA-SORE sustains sorafenib resistance in hepatocellular carcinoma by regulating β-catenin…

10 Dec 2020

Reply Repost Favourite

RT @jonmoulton: N6-methyladenosine-modified CircRNA-SORE sustains sorafenib resistance in hepatocellular carcinoma by regulating β-catenin…

23 Nov 2020

Reply Repost Favourite

N6-methyladenosine-modified CircRNA-SORE sustains sorafenib resistance in hepatocellular carcinoma by regulating β-catenin signaling. https://t.co/oP1OjENGvy Blocking an adenosine methylation site (N6) in a circular RNA with a #Morpholino

23 Nov 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.